ArticleAmerican journal of translational research2026
Effect of minimally invasive sternocleidomastoid release on muscle regeneration in children with congenital muscular torticollis.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the clinical efficacy of minimally invasive small-incision sternocleidomastoid (SCM) muscle release in the treatment of congenital muscular torticollis (CMT) in children and its regulatory effect on abnormal regeneration of the SCM muscle.
methodsA retrospective analysis was conducted on 178 children with CMT who underwent minimally invasive small-incision SCM release at Qinghai Provincial Women and Children's Hospital from January 2022 to December 2024. All children completed a 12-month follow-up. Clinical efficacy scores, SCM muscle thickness, and echogenicity were measured preoperatively, 1, 6, and 12 months postoperatively. The excellent and good rate of clinical efficacy was statistically analyzed, and changes in ultrasound indicators and postoperative complication rate were statistically analyzed to evaluate the therapeutic effect and safety of the surgery.
resultsThe total clinical efficacy score at each postoperative time point was significantly higher than that before surgery (P<0.001), with the excellent efficacy rate reaching 77.53% at 12 months postoperatively. The thickness and echogenicity of the SCM muscle showed a continuous downward trend at each postoperative time point, compared with preoperative values (all P<0.001). Ten mild complications occurred postoperatively, with a total complication rate of 5.62%. All symptoms were relieved after symptomatic treatment, and no serious adverse events occurred.
conclusionMinimally invasive small-incision SCM release is clinically effective in the treatment of children with CMT. It can effectively improve cervical motor function and craniofacial appearance, inhibit abnormal SCM muscle regeneration, and has high safety and few complications. For children with CMT who fail to respond to conservative treatment, this procedure is an ideal surgical treatment option and has good clinical application value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.